The global human platelet lysate market size was valued at USD 54.42 Million in 2025. The market is being driven by the rising incidences of various health-related issues and increasing investments in R&D activities of stem cell therapy. The market is anticipated to grow at a CAGR of 3.60% during the forecast period 2026-2035 to reach a value of USD 77.51 Million by 2035.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
3.6%
Value in USD Million
2026-2035
*this image is indicative*
The growth of the human platelet lysate or hPL market is being driven by the growing incidences of chronic autoimmune diseases, haematological and neurological disorders, and cardiovascular and infectious diseases, among others. This, in turn, is increasing the applications of progenitor and stem cell-based therapies, hence surging the demand. With the increasing focus on quality issues regarding purity, traceability, potency, safety, and identity of hPLs, the market is poised to witness lucrative growth opportunities in the coming years.
North America holds a significant share of the market, which can be attributed to their extensive utilisation of hPL as a substitute for fetal bovine serum in various applications. Surging investments in research and development (R&D) activities of stem cell therapy by leading companies and governments are bolstering the growth of the market. For instance, in March 2020, the Canadian government announced an investment of about USD 7 million in regenerative medicine and stem cell research.
Meanwhile, Europe is anticipated to be one of the fastest-growing regional markets. This can be associated with the rising use of hPL in manufacturing cell therapeutics due to ethical issues pertaining to animal-derived raw materials in the region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Human platelet lysate or hPL refers to a cell culture supplement that is typically used as an alternative to fetal bovine serum (FBS) for human cell propagation and culture. It is manufactured from intermediate side products of whole blood donations and is rich in growth factors and chemokine molecules. In addition, the product is used to grow mesenchymal stem cells that are derived from diverse species like rabbits and humans, among others.
Market Breakup by Type
Market Breakup by Applications
Market Breakup by End User
Market Breakup by Distribution Channel
Market Breakup by Region
The growing interest in cell-based therapies such as mesenchymal stem cell-based therapy is leading to a surge in demand. As growth supplements like foetal bovine serum (FBS) are xenogeneic products and can induce immunologic reactions, hPL is deployed as their alternative.
Advancements in pathogen reduction technologies to boost the safety of hPL are also likely to fuel the market growth. The increasing research and development (R&D) activities to identify the potential of the cell culture growth supplement in the production of clinical-grade cell therapy products are anticipated to provide impetus to market growth.
Due to the growing ethical and animal welfare concerns in the medical and pharmaceutical sectors, hPL is increasingly preferred as it can be produced from outdated platelets. Its surging use for research-grade expansion of endothelial colony-forming progenitor cells is also expected to significantly contribute to the growth of the market. With increasing clinical trials and research activities, the demand for the product in human cell expansion is rising, propelling the growth of the market in the coming years.
The report presents a detailed analysis of the following key players in the global human platelet lysate market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the market. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Upto 15% Off
USD
$5499 $4949
$3299 $2969
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global human platelet lysate market reached a value of USD 54.42 Million in 2025.
The market is projected to grow at a CAGR of 3.60% during the forecast period of 2026-2035 to reach a value of USD 77.51 Million by 2035.
The market is being aided by the rising incidences of various health-related issues, a growing focus on characterising and defining quality issues of hPLs, and increasing investments in R&D activities of stem cell therapy.
The market is likely to be supported by the rising interest in cell-based therapies, advancements in pathogen reduction technologies, and the growing ethical and animal welfare concerns in the pharmaceutical and medical sectors.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific. North America currently holds a significant market share, while Europe is projected to witness fast growth.
The major types of hPL in the market are heparin-based human platelet lysate and heparin-free human platelet lysate, among others.
The various end uses of hPL are pharmaceutical and biotechnology companies, academic and research institutes, and others.
The significant applications in the market are research and therapeutic.
The major players in the market are Merck KGaA, Compass Biomedical, Inc., STEMCELL Technologies Inc., Sartorius AG, and Life Science Group Ltd.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share